|
1
|
Lin H, van den Esschert J, Liu C and van
Gulik TM: Systematic review of hepatocellular adenoma in China and
other regions. J Gastroenterol Hepatol. 26:28–35. 2011. View Article : Google Scholar
|
|
2
|
Tanaka M, Katayama F, Kato H, Tanaka H,
Wang J, Qiao YL and Inoue M: Hepatitis B and C virus infection and
hepatocellular carcinoma in China: A review of epidemiology and
control measures. J Epidemiol. 21:401–416. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sia D and Villanueva A: Signaling pathways
in hepatocellular carcinoma. Oncology. 81(Suppl 1): 18–23. 2011.
View Article : Google Scholar
|
|
4
|
Qin LX: Recent progress in predictive
biomarkers for metastatic reccurrence of human hepatocellular
carcinoma: A review of the literature. J Cancer Res Clin Oncol.
130:497–513. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tabrizian P, Franssen B, Jibara G, Sweeney
R, Sarpel U, Schwartz M and Labow D: Cytoreductive surgery with or
without hyperthermic intraperitoneal chemotherapy in patients with
peritoneal hepatocellular carcinoma. J Surg Oncol. 110:786–790.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hermanson DJ and Marnett LJ: Cannabinoids,
endocan-nabinoids, and cancer. Cancer Metastasis Rev. 30:599–612.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bowles DW, O'Bryant CL, Camidge DR and
Jimeno A: The intersection between cannabis and cancer in the
United States. Crit Rev Oncol Hematol. 83:1–10. 2012. View Article : Google Scholar
|
|
8
|
Giuliano M, Pellerito O, Portanova P,
Calvaruso G, Santulli A, De Blasio A, Vento R and Tesoriere G:
Apoptosis induced in HepG2 cells by the synthentic cannabinoid WIN:
Involvement of the transcription factor PPARgamma. Biochimie.
91:457–465. 2009. View Article : Google Scholar
|
|
9
|
Calvaruso G, Pellerito O, Notaro A and
Giuliano M: Cannabinoid-associated cell death mechanisms in tumor
models (review). Int J Oncol. 41:407–413. 2012.PubMed/NCBI
|
|
10
|
Chakravarti B, Ravi J and Ganju RK:
Cannabinoids as therapeutic agents in cancer: Current status and
future implications. Oncotarget. 5:5852–5872. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sarfaraz S, Afaq F, Adhami VM, Malik A and
Mukhtar H: Cannabinoid receptor agonist-induced apoptosis of human
prostate cancer cells LNCaP proceeds through sustained activation
of ERK1/2 leading to G1 cell cycle arrest. J Biol Chem.
281:39480–39491. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hong Y, Zhou Y, Wang Y, Xiao S, Liao DJ
and Zhao Q: PPARγ mediates the effects of WIN55,212-2, an synthetic
cannabinoid, on the proliferation and apoptosis of the BEL-7402
hepatocarcinoma cells. Mol Biol Rep. 40:6287–6293. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Preet A, Qamri Z, Nasser MW, Prasad A,
Shilo K, Zou X, Groopman JE and Ganju RK: Cannabinoid receptors,
CB1 and CB2, as novel targets for inhibition of non-small cell lung
cancer growth and metastasis. Cancer Prev Res (Phila). 4:65–75.
2011. View Article : Google Scholar
|
|
14
|
Xian XS, Park H, Choi MG and Park JM:
Cannabinoid receptor agonist as an alternative drug in
5-fuorouracil-resistant gastric cancer cells. Anticancer Res.
33:2541–2547. 2013.PubMed/NCBI
|
|
15
|
Brandi J, Dando I, Palmieri M, Donadelli M
and Cecconi D: Comparative proteomic and phosphoproteomic profiling
of pancreatic adenocarcinoma cells treated with CB1 or CB2
agonists. Electrophoresis. 34:1359–1368. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Dainese E, Oddi S, Bari M and Maccarrone
M: Modulation of the endocannabinoid system by lipid rafts. Curr
Med Chem. 14:2702–2715. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zeni O, Sannino A, Romeo S, Micciulla F,
Bellucci S and Scarf MR: Growth inhibition, cell-cycle alteration
and apoptosis in stimulated human peripheral blood lymphocytes by
multi-walled carbon nanotube buckypaper. Nanomedicine (Lond).
10:351–360. 2015. View Article : Google Scholar
|
|
18
|
Sánchez I and Dynlacht BD: New insights
into cyclins, CDKs, and cell cycle control. Semin Cell Dev Biol.
16:311–321. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kumar P and Wood C: Kaposi's
sarcoma-associated herpesvirus transactivator Rta induces cell
cycle arrest in G0/G1 phase by stabilizing and promoting nuclear
localization of p27kip. J Virol. 87:13226–13238. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Deshpande A, Sicinski P and Hinds PW:
Cyclins and cdks in development and cancer: A perspective.
Oncogene. 24:2909–2915. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ma X, Gao Y, Fan Y, Ni D, Zhang Y, Chen W,
Zhang P, Song E, Huang Q, Ai Q, et al: Overexpression of E2F1
promotes tumor malignancy and correlates with TNM stages in clear
cell renal cell carcinoma. PLoS One. 8:e734362013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Johnson JL, Pillai S, Pernazza D, Sebti
SM, Lawrence NJ and Chellappan SP: Regulation of matrix
metalloproteinase genes by E2F transcription factors: Rb-Raf-1
interaction as a novel target for metastatic disease. Cancer Res.
72:516–526. 2012. View Article : Google Scholar :
|
|
23
|
Pillai S, Kovacs M and Chellappan S:
Regulation of vascular endothelial growth factor receptors by Rb
and E2F1: Role of acetylation. Cancer Res. 70:4931–4940. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lukaszewicz-Zając M, Mroczko B and
Szmitkowski M: Gastric cancer - The role of matrix
metalloproteinases in tumor progression. Clin Chim Acta.
412:1725–1730. 2011. View Article : Google Scholar
|
